King Luther Capital Management Corp Has $169.15 Million Position in Stryker Corporation $SYK

King Luther Capital Management Corp lifted its stake in shares of Stryker Corporation (NYSE:SYK) by 4.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 481,259 shares of the medical technology company’s stock after purchasing an additional 19,606 shares during the quarter. King Luther Capital Management Corp’s holdings in Stryker were worth $169,148,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in SYK. VanderPol Investments L.L.C. increased its stake in shares of Stryker by 1.4% during the 4th quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company’s stock worth $732,000 after purchasing an additional 28 shares during the last quarter. Lantz Financial LLC lifted its stake in Stryker by 5.0% in the third quarter. Lantz Financial LLC now owns 608 shares of the medical technology company’s stock valued at $225,000 after purchasing an additional 29 shares during the last quarter. Stonebridge Capital Advisors LLC lifted its stake in Stryker by 0.4% in the third quarter. Stonebridge Capital Advisors LLC now owns 7,198 shares of the medical technology company’s stock valued at $2,661,000 after purchasing an additional 29 shares during the last quarter. Tcfg Wealth Management LLC grew its holdings in Stryker by 2.7% during the third quarter. Tcfg Wealth Management LLC now owns 1,091 shares of the medical technology company’s stock valued at $403,000 after purchasing an additional 29 shares during the period. Finally, Sompo Asset Management Co. Ltd. grew its holdings in Stryker by 1.3% during the second quarter. Sompo Asset Management Co. Ltd. now owns 2,390 shares of the medical technology company’s stock valued at $946,000 after purchasing an additional 30 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, VP M Kathryn Fink sold 3,500 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president directly owned 177 shares of the company’s stock, valued at approximately $50,170.65. This represents a 95.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.

Stryker Price Performance

Stryker stock opened at $313.08 on Wednesday. The firm has a market capitalization of $120.02 billion, a P/E ratio of 36.24, a PEG ratio of 1.99 and a beta of 0.80. Stryker Corporation has a one year low of $281.00 and a one year high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The business has a fifty day moving average price of $324.33 and a 200-day moving average price of $349.12.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts forecast that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio is currently 40.74%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on SYK. Jefferies Financial Group restated a “buy” rating and issued a $465.00 target price on shares of Stryker in a research note on Wednesday, March 4th. Wall Street Zen lowered Stryker from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Evercore set a $355.00 price objective on Stryker in a research note on Friday, May 1st. Leerink Partners started coverage on shares of Stryker in a report on Monday, April 13th. They set an “outperform” rating and a $410.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Stryker in a research report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.